These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 1026366

  • 41. Renal artery stenosis with normal angiotensin II values. Relationship between angiotensin II and body sodium and potassium on correction of hypertension by captopril and subsequent surgery.
    Atkinson AB, Brown JJ, Davies DL, Leckie B, Lever AF, Morton JJ, Robertson JI.
    Hypertension; 1981; 3(1):53-8. PubMed ID: 7009427
    [Abstract] [Full Text] [Related]

  • 42. Pheochromocytoma and vasodepressor response to saralasin.
    Zawada ET, Dornfeld L, Maxwell M, Marks L, Kaufman JJ.
    Ann Intern Med; 1979 Sep; 91(3):494-5. PubMed ID: 475193
    [No Abstract] [Full Text] [Related]

  • 43. Infusion of angiotensin-II analogue in two patients with unilateral renovascular hypertension.
    Donker AJ, Leenen FH.
    Lancet; 1974 Dec 28; 2(7896):1535-7. PubMed ID: 4140980
    [No Abstract] [Full Text] [Related]

  • 44. Use of angiotensin antagonists in experimental and human renovascular hypertension.
    Maxwell MH.
    Adv Nephrol Necker Hosp; 1979 Dec 28; 8():297-319. PubMed ID: 115245
    [No Abstract] [Full Text] [Related]

  • 45. Physiologic definition of blood pressure response to renal revascularization in patients with renovascular hypertension.
    Vaughan ED, Carey RM, Ayers CR, Peach MJ, Tegtmeyer CJ, Wellons HA.
    Kidney Int Suppl; 1979 Mar 28; (9):S83-92. PubMed ID: 289868
    [No Abstract] [Full Text] [Related]

  • 46. Saralasin infusion in screening patients for renovascular hypertension.
    Krakoff LR, Ribeiro AB, Gorkin JU, Felton KR.
    Am J Cardiol; 1980 Mar 28; 45(3):609-13. PubMed ID: 6986750
    [Abstract] [Full Text] [Related]

  • 47. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
    Brown JJ, Brown WC, Fraser R, Lever AF, Morton JJ, Robertson JI, Rosei EA, Trust PM.
    Prog Biochem Pharmacol; 1976 Mar 28; 12():230-41. PubMed ID: 1019166
    [Abstract] [Full Text] [Related]

  • 48. Angiotensin II blockade by saralasin in the evaluation of hypertension in children.
    Favre L, Boerth RC, Braren V, Dean RH, Hollifield JW.
    Kidney Int Suppl; 1979 Mar 28; (9):S75-82. PubMed ID: 289867
    [No Abstract] [Full Text] [Related]

  • 49. [Hemodynamics, renin and aldosterone following angiotensin II blockade and sodium chloride deficiency in hypertensive subjects].
    Beyer J, Liebau G, Steiner B, Schick K, Hayduk K.
    Verh Dtsch Ges Kreislaufforsch; 1977 Mar 28; 43():212-3. PubMed ID: 613577
    [No Abstract] [Full Text] [Related]

  • 50. [Renovascular hypertension. Concepts and reality].
    Ménard J, Corvol P, Plouin PF, Lagneau P.
    Arch Mal Coeur Vaiss; 1979 Nov 28; 72 Spec no():5-8. PubMed ID: 43713
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Role of the renin-angiotensin system in hypertension produced by unilateral renal artery constriction in the rat.
    Oates HF.
    Clin Exp Pharmacol Physiol; 1976 Nov 28; 3(1):95-8. PubMed ID: 971555
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Reactive hyper-reninaemia to angiotensin blockade identifies renovascular hypertension.
    Case DB, Atlas SA, Laragh JH.
    Clin Sci (Lond); 1979 Dec 28; 57 Suppl 5():313s-316s. PubMed ID: 232024
    [Abstract] [Full Text] [Related]

  • 56. Effects of 1-Sar-8-Ala-angiotensin II on systemic and pulmonary haemodynamics in hypertensive patients.
    Fagard R, Amery A, Lijnen P, Reybrouck T, Joossens JV, Billiet L, Moerman E, De Schaepdryver A.
    Clin Exp Pharmacol Physiol; 1978 Dec 28; 5(5):457-64. PubMed ID: 729204
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.